Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rasha Irshad

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Toxicology and Applied Pharmacology|February 25, 2021
Natural products in the reprogramming of cancer epigeneticsRasha Irshad, Mohammad Husain
Current Topics in Medicinal Chemistry|May 23, 2023
Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic PerspectivesRasha Irshad, Sazi Tabassum, Mohammad Husain
Frontiers in Pharmacology|October 31, 2022
Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancerRasha Irshad, Nafis Raj, Gamal A Gabr, et al.
Toxicology and Applied Pharmacology|May 25, 2024
Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based studyRasha Irshad, Faiqah Batool, Nafis Raj, et al.
Life Sciences|July 24, 2019
TLRs in pulmonary diseasesShweta Arora, Shaniya Ahmad, Rasha Irshad, et al.
Scientific Reports|May 31, 2018
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibitionFarid Ahmad Siddiqui, Gopinath Prakasam, Shilpi Chattopadhyay, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Toxicology and Applied Pharmacology|February 25, 2021
Natural products in the reprogramming of cancer epigeneticsRasha Irshad, Mohammad Husain
Current Topics in Medicinal Chemistry|May 23, 2023
Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic PerspectivesRasha Irshad, Sazi Tabassum, Mohammad Husain
Frontiers in Pharmacology|October 31, 2022
Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancerRasha Irshad, Nafis Raj, Gamal A Gabr, et al.
Toxicology and Applied Pharmacology|May 25, 2024
Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based studyRasha Irshad, Faiqah Batool, Nafis Raj, et al.
Life Sciences|July 24, 2019
TLRs in pulmonary diseasesShweta Arora, Shaniya Ahmad, Rasha Irshad, et al.
Scientific Reports|May 31, 2018
Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibitionFarid Ahmad Siddiqui, Gopinath Prakasam, Shilpi Chattopadhyay, et al.
Pageof 1